Monograph Template
From Pubdrug
This template is a final working version for contributors to use for adding individual drug monographs to the site. This is not a standard MediaWiki-style "template," rather a working outline of the information that would appear in such a template and it's general orientation and organization on the page.
Drug monograph objectives:
- Thoroughness -- Monographs should include all informational facets of any particular drug.
- Readability -- Sections and subsections of the monograph should be clearly labeled.
- Functionality -- Sections and subsections of the monograph should have clear and consistent purpose and use.
- Appearance -- The overall look of a drug monograph should be clean, uncluttered.
Note: The section of the monograph containing all drug interaction information was reconstructed upon the last edit of the PubDrug monograph template. There is no drug interaction information on the drug's main page. The interaction information is contained on a separate page, to be titled '(insert drug name here) drug interactions' (note use of all small letters). That template can be found here.
Please mark edits with your own notes and use the Discussion tab to talk over details of the template with PubDrug contributors.
This page was designed to guide the creation of a new medication monograph. For our continued effort to preserve a standardized format for transferability of data and ease in clinical utility, please conform to the template as much as possible. Creativity with linking, sub-paging, etc. is encouraged, however if major formatting changes are made, we ask that you discuss the changes with the editor(s) before finalizing. If a major formatting change is implemented as a result of your creativity, it is expected that you will aid in retrospectively editing all existing medication monographs to include such additions.
Remember, this database is created by professionals for professional use and it should go without saying that professional conduct is expected in all aspects of monograph creation, including cooperation with the editorial staff. We truly appreciate your time and effort.
See an example of a completed drug monograph.
COPY AND PASTE EVERYTHING IN THE GREY BOX BELOW INTO A NEW PAGE.
<!-- IF A DRUG HAS A BLACK BOX WARNING, REMOVE THIS COMMENT TAG AND TYPE {{Blackbox}} (SEE OLANZAPINE PAGE FOR EXAMPLE) -->
{{Druginfo
|author = author signature (type four tildes)
|certifier = certifier signature (type four tildes)
|drug name = Type drug name here (e.g. Atorvastatin)
|image = Type image name here (.png file extension already included)
|Review Color = red
|phonetics = type phonetics here
|brand = type brand name(s) here
|supplied = type dosage form: strengths <!-- SEPARATE TWO DOSAGE FORMS w/ <br> -->
|gen avail = if no, type "No generics available"...if yes, type "all" to denote all strengths or type available generic strengths
|patent exp = type date on which patent expires
|class = type class of drug
|schedule = type schedule of drug (CII, CIII, CIV, CV, Rx, OTC)
|preg cat = type pregnancy category (A,B,C,D,X)
|breast feed = type a brief description of breast feeding cautions if any
|IUPAC name = type IUPAC name <!-- DO NOT USE DOUBLE BRACKETS ( [[ OR ]] ) -->
|emp formula = type empirical formula
|MW = type molecular weight
|genomicsURL = enter genomics URL (SEE www.pharmgkb.org)
}}
== <p style="background:#FEFEEF">Description</p> ==
In paragraph form, briefly describe the drug, how it works, and what it is used for.
== <p style="background:#FEFEEF">Mechanism of Action</p> ==
In paragraph form, briefly describe the mechanism of action. If unknown, state the mechanism is unknown.
== <p style="background:#FEFEEF">Time Required for Therapeutic Response</p> ==
* Initial: type initial response time
* Maximum: type maximum response time
== <p style="background:#FEFEEF">Pharmacokinetics</p> ==
'''Absorption'''<br>
Describe absorption characteristics of the drug.
'''Distribution'''<br>
Describe distribution characteristics of the drug.
'''Metabolism'''<br>
Describe metabolism characteristics of the drug.
'''Excretion'''<br>
Describe excretion characteristics of the drug.
<br>
<br>
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
== <p style="background:#FEFEEF">Special Population Pharmacokinetics</p> ==
* '''Renal insufficiency:''' Type renal insufficiency PK.
* '''Hepatic insufficiency:''' Type hepatic insufficiency PK.
* '''Hemodialysis:''' Type hemodialysis PK.
* '''Geriatric:''' Type geriatric PK.
* '''Pediatric:''' Type pediatric PK.
* '''Gender:''' Type gender difference PK.
== <p style="background:#FEFEEF">Indications and Dosages</p> ==
=== FDA Approved Indications ===
'''Put FDA-approved indications in bold'''
* Starting dose:
**and put starting dose below
**using bullet points
* Maintenance dose:
**put maintenance dosing below
**using bullet points
* Titration schedule: if any, type here (how to titrate the drug up or down), if not, erase the bullet point.
'''Add as many indications as necessary'''
* Starting dose:
**and put starting dose below
**using bullet points
* Maintenance dose:
**put maintenance dosing below
**using bullet points
* Titration schedule: if any, type here (how to titrate the drug up or down), if not, erase the bullet point.
=== Non-FDA Approved Indications ===
* Put non-FDA-approved indications here. Use a bullet point for each indication. Dosing for these indications is unnecessary.
=== Dosage Adjustment === <!--IF NO DOSAGE ADJUSTMENT NEEDED, ERASE THE LINE. KEEP THE BREAKS (<br>) BETWEEN LINES FOR STYLING PURPOSES-->
'''Renal insufficiency:''' type renal insufficiency dosage adjustment here - use bullet points if necessary.<br>
'''Hepatic insufficiency:''' type hepatic insufficiency dosage adjustment here.<br>
'''Hemodialysis:''' type hemodialysis dosage adjustment here.<br>
'''Geriatric:''' type geriatric dosage adjustment here.<br>
'''Pediatric:''' type pedatric dosage adjustment here.<br>
'''Gender:''' type gender dosage adjustment here.
=== Dosage Limits ===
* '''Adults:''' enter adult dosing limit
* '''Elderly:''' enter elderly dosing limit
* '''Adolescents and children:''' enter adolescent/children dosing limit (may be different, especially for small children and neonates...use extra bullet points for these special populations if necessary
<br>
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
== <p style="background:#FEFEEF">Administration</p> ==
* '''Route:''' type route of administration (e.g. oral, rectal, vaginal, etc.)
* '''Method:'''
** Describe how it is to be taken for this route
** Add extra bullet points if necessary
* '''Route:''' if you have more than one route use more bullet points
* '''Method:'''
** Keep the same format throughout!
== <p style="background:#FEFEEF">Monitoring Parameters</p> ==
* Enter monitoring parameters using bullet points.
* Use as many as you need.
== <p style="background:#FEFEEF">Contraindications/Precautions</p> ==
<!-- IF A DRUG HAS A BLACK BOX WARNING, REMOVE THE 'CARAT, EXCLAMATION POINT, TWO DASH' SYMBOL AT THE BEGINNING, ALL OF THIS TEXT, AND THE 'TWO DASH, CARAT' SYMBOL AFTER THE BLACK BOX WARNING SECTION. IF A DRUG HAS NO BLACK BOX WARNING, DO NOT EDIT THIS COMMENT OR THE BLACK BOX SECTION
=== Black box warning ===
Explain black box warning in paragraph form.
-->
=== Contraindications ===
* '''Enter contraindications using bullet points. Make sure this text is bold.'''
* '''Another contraindication'''
=== Precautions ===
* Enter precautions using bullet points
* Another precaution
=== Pregnancy indications ===
<span style="background:#FFFEDD">'''Category ENTER PREGNANCY CATEGORY LETTER'''</span>
Type a brief explanation of the pregnancy category.
=== Breast-feeding indications ===
Type a brief explanation of the breastfeeding indications.
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
<!--
********READ ME: BEFORE YOU CREATE THE DRUG INTERACTIONS PAGE, BE SURE TO CHANGE THE TEXT FOR THE DRUG NAME BELOW********
-->
== <p style="background:#FEFEEF">[[TYPE DRUG NAME HERE drug interactions | Drug-Drug, -Food, -Herb Interactions]]</p> ==
Click the link above to go to the drug interactions page.
== <p style="background:#FEFEEF">Adverse Reactions/Side Effects</p> ==
<!--
BE SURE TO ENTER DRUG NAME BELOW. IF THERE ARE NO ADVERSE REACTIONS IN A PARTICULAR BODY SYSTEM, PLEASE REMOVE THAT ROW FROM THE TABLE. THE ROW STARTS WITH "|-" AND ENDS AT THE LINE BEFORE THE NEXT "|-". IF YOU REMOVE ROWS, YOU MUST CHANGE THE ROWSPAN IN THE CNS LINE FROM 8 (rowspan="8") AND SUBTRACT THE NUMBER OF ROWS YOU DELETED.
-->
{| style="width:100%" border="1" align="center"
|+ '''TYPE DRUG NAME HERE Adverse Reactions Chart'''
|- style="background:#EFEFFF" align="center"
| '''Incidence''' || '''Body System''' || '''Adverse Reactions'''
|- style="background:#FFFFCC" align="center"
| '''>10%''' || All || style="padding-left:0.5em" align="left"| ENTER ALL ADVERSE REACTIONS WITH AN INCIDENCE OF >10% HERE (be sure to include the percent at which they occur)
|- style="background:#FFFEDD" align="center"
| rowspan="8" | '''1-10%'''|| CNS || style="padding-left:0.5em" align="left"| TYPE CNS ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| Cardiovascular || style="padding-left:0.5em" align="left"| TYPE CARDIOVASCULAR ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| Dermatologic || style="padding-left:0.5em" align="left"| TYPE DERMATOLOGIC ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| GI || style="padding-left:0.5em" align="left"| TYPE GI ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| Genitourinary || style="padding-left:0.5em" align="left"| TYPE GENITOURINARY ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| Neuromuscular/skeletal || style="padding-left:0.5em" align="left"| TYPE NEUROMUSCULAR/SKELETAL ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| Respiratory || style="padding-left:0.5em" align="left"| TYPE RESPIRATORY ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FFFEDD" align="center"
| Miscellaneous || style="padding-left:0.5em" align="left"| TYPE MISCELLANEOUS ADVERSE EFFECTS OCCURRING AT 1-10%
|- style="background:#FEFEEF" align="center"
| '''<1%''' || All || style="padding-left:0.5em" align="left"| ENTER ALL ADVERSE REACTIONS WITH AN INCIDENCE OF <1% HERE (just a list is sufficient)
|}
== <p style="background:#FEFEEF">Overdosage Measures</p> ==
Brief description of overdose, including how it may manifest.
<br>
'''Treatment:'''
* Enter treatment using bullet points.
* Add additional bullet points if needed.
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
== <p style="background:#FEFEEF">Product Information and Distribution</p> ==
<!--
FOR THIS SECTION, ONLY INCLUDE THE BRAND NAME TABLET/SOLUTION APPEARANCE. DO NOT INCLUDE GENERICS. ADD OR SUBTRACT ROWS AS NECESSARY.
-->
{| style="width:100%;" border="1" align="center"
|+ '''Note: appearance only available for brand-name product'''
|- style="background:#EFEFFF" align="center"
| '''Dose/form''' || '''Drug color(s)'''|| '''Drug shape''' || '''Markings or odor/flavor'''
|- style="background:#FEFEEF" align="center"
| style="background:#EFEFFF" | '''5 mg tablet''' || purple || round || 3167/M
|- style="background:#FEFEEF" align="center"
| style="background:#EFEFFF" | '''10 mg tablet''' || green || round || 3168/M
|- style="background:#FEFEEF" align="center"
| style="background:#EFEFFF" | '''20 mg tablet''' || yellow || triangle || 3169/M
|- style="background:#FEFEEF" align="center"
| style="background:#EFEFFF" | '''10 mg/5 mL solution''' || clear || - || orange flavor
|}
* '''Inactive ingredients for tablets:''' add inactive ingredients
* '''Inactive ingredients for solution:''' add inactive ingredients
== <p style="background:#FEFEEF">Patient Information</p> ==
* Type patient information using bullet points.
* Use as many bullet points as you need.
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
== <p style="background:#FEFEEF">References</p> ==
<references/>
== <p style="background:#FEFEEF">PUBMED References</p> ==
=== Efficacy Trial Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
=== Therapeutic Class Comparison Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
=== Pharmacokinetics Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
=== Drug Interaction Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
=== Adverse Effects Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
=== Compliance Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
=== Pharmacoeconomic Articles ===
# type links to articles - use PUBMED links to abstracts
# add as many as needed
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
== <p style="background:#FEFEEF">External Links</p> ==
'''Clinical treatment guidelines'''
* add clinical treatment guideline external links, if applicable, using bullet points
* do not link to websites that have a bias to a particular drug, such as manufacturer-sponsored information sites
'''Patient information pages'''
* add patient information external links, if applicable, using bullet points
* do not link to websites that have a bias to a particular drug, such as manufacturer-sponsored information sites
'''Other resources'''
* add other resources using bullet points
* do not link to websites that have a bias to a particular drug, such as manufacturer-sponsored information sites
{| style="width:100px; border:2px solid #FFFF99; background:#FEFEEF" align="center"
|- align="center"
| [[#top|'''Back to top''']]
|}
